Cargando…
Experience with long-term rituximab use in a multiple sclerosis clinic
BACKGROUND: Rituximab is a monoclonal antibody directed at CD20 positive B-lymphocytes and a potential therapeutic option in the treatment of multiple sclerosis. The safety of recurrent dosing is not established. OBJECTIVES: The objective of this work was to report the experience of long-term rituxi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433395/ https://www.ncbi.nlm.nih.gov/pubmed/28607739 http://dx.doi.org/10.1177/2055217316672100 |